vitamin C

Four grams a day of vitamin C wasn't beneficial in type 1A Charcot-Marie-Tooth disease, but the trial yielded advances in CMT trial design

posted on June 27, 2013 - 10:15am
An MDA-supported trial of high-dose ascorbic acid (vitamin C) in the type 1A form of Charcot-Marie-Tooth disease (CMT) (CMT1A) did not find a benefit for this treatment, although it appeared safe and was generally well-tolerated. There were no serious adverse events judged to be related to the study drug.
posted on May 1, 2008 - 10:21am
QUEST Vol. 15, No. 3
This article includes items about: Duchenne muscular dystrophy, limb-girdle muscular dystrophy, Becker muscular dystrophy, myotonic muscular dystrophy, fascioscapulohumeral muscular dystrophy, Charcot-Marie-Tooth disease, spinal muscular atrophy, Friedreich's ataxia, myasthenia gravis and centronuclear myopathy
posted on September 1, 2007 - 11:06am
QUEST Vol. 14, No. 5
Featured in this issue: News about clinical trials in Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, Pompe disease and myotonic muscular dystrophy type 1
posted on April 1, 2007 - 10:16am
QUEST Vol. 14, No. 4
Canadian team will pursue cell transplants in men with DMD, BMD
posted on July 1, 2004 - 4:26pm
Vitamin C aids CMT1A mice High doses of ascorbic acid (vitamin C) can improve or stabilize motor function in mice with a particular form of Charcot-Marie-Tooth (CMT) disease, say researchers in France, who published their results in the April issue of Nature Medicine.